TickerFacts.

908 Devices Inc. (MASS): Cost of Revenue

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2024-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$27.77M
Year ended 2025-12-31
$29.11M
Trailing 12 months to 2026-06-30
2020-12-31: $11.97M2021-12-31: $18.97M2022-12-31: $20.83M2023-12-31: $24.91M2024-12-31: $23.25M2025-12-31: $27.77M$27.77M
2020-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$27.77M+19.5%2026-03-09, From 2025-01-01
2024-12-31$23.25Mn/c2026-03-09, From 2024-01-01
2023-12-31$24.91M+19.6%2025-03-07, From 2023-01-01
2022-12-31$20.83M+9.8%2024-03-08, From 2022-01-01
2021-12-31$18.97M+58.5%2023-03-15, From 2021-01-01
2020-12-31$11.97Mn/a2022-03-11, From 2020-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Laboratory Analytical Instruments), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
908 Devices Inc. (MASS)2025-12-31$27.77M+19.5%
Harvard Bioscience Inc (HBIO)2025-12-31$36.64M-6.9%
Bionano Genomics, Inc. (BNGO)2025-12-31$15.32M-49.6%
Precipio, Inc. (PRPO)2025-12-31$13.34M+21.6%
Quanterix Corp (QTRX)2025-12-31$73.94M+36.1%
Pacific Biosciences of California, Inc. (PACB)2025-12-31$114.22M-2.1%
Seer, Inc. (SEER)2025-12-31$8.11M+14.0%
Cytek Biosciences, Inc. (CTKB)2025-12-31$97.03M+8.6%
Lifeloc Technologies, Inc (LCTC)2025-12-31$5.38M+5.8%

Compare MASS, HBIO, BNGO, PRPO side by side · Screen every company in Laboratory Analytical Instruments ↗